Human papillomavirus infection in women with and without cervical cancer in Nepal

Cancer Causes and Control

Volumn 21, Issue 3, 2010, Pages 323-330

  Sherpa, Ang Tshering Lama ^a,b   Clifford, Gary M ^c   Vaccarella, Salvatore ^c   Shrestha, Sadhina ^d   Nygard, Mari ^e   Karki, Balman Singh ^a   Snijders, Peter J F ^f   Meijer, Chris J L M ^f   Franceschi, Silvia ^c  

^a KIST MEDICAL COLLEGE   (Nepal)

^b UNIVERSITY OF OSLO   (Norway)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d BP Koirala Memorial Cancer Hospital   (Nepal)

^e CANCER REGISTRY OF NORWAY   (Norway)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cervical cancer; Human papillomavirus; Nepal; Prevalence

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CHINA; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; EDUCATIONAL STATUS; ENDOMETRIAL DISEASE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; INDIA; INFECTION PREVENTION; MAJOR CLINICAL STUDY; NEPAL; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; SEXUALITY; SOCIAL BEHAVIOR; SOCIAL STATUS; SQUAMOUS EPITHELIUM; UTERINE CERVIX CANCER; VACCINATION; VIRUS DETECTION;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COMORBIDITY; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEPAL; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 77950692151     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9467-z     Document Type: Article

References (33)

1. United Nations Educational Scientific and Cultural Organization (2006) EFA Global Monitoring Report. Available from URL: http://gmr.uis.unesco.org/ selectindicators.aspx
2. The World Bank Group (2006) 2006 World Development Indicators. Table 2.7: Poverty. Available from URL: http://devdata. worldbank.org/wdi2006/contents/ Section2.htm
3. World Health Organization (2006) The world health report 2006: working together for health. World Health Organization, Geneva
4. B.P. Koirala Memorial Cancer Hospital (Nepal) (2004) Annual report 2003. B.P. Koirala Memorial Cancer Hospital, Chitawan
5. Maucort-Boulch D, Franceschi S, Plummer M (2008) International correlation between human papillomavirus prevalence and cervical cancer incidence. Cancer Epidemiol Biomarkers Prev 17:717-720 (Pubitemid 351469225)
6. Kahn JA, Burk RD (2007) Papillomavirus vaccines in perspective. Lancet 369:2135-2137
7. Qiao YL, Sellors JW, Eder PS et al. (2008) A new HPV-DNA test for cervical-cancer screening in developing regions: a crosssectional study of clinical accuracy in rural China. Lancet Oncol 9:929-936
8. Sankaranarayanan R, Nene BM, Shastri SS et al. (2009) HPV Screening for cervical cancer in rural India. N Engl J Med 360:1385-1394
9. Clifford GM, Gallus S, Herrero R et al. (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366:991-998 (Pubitemid 41323035)
10. Roda Husman AM, Snijders PJ, Stel HV, van den Brule AJ, Meijer CJ, Walboomers JM (1995) Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 72:412-417
11. Jacobs MV, Walboomers JM, Snijders PJ et al. (2000) Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 87:221-227
12. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ (2002) GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40:779-787 (Pubitemid 34208623)
13. Muñoz N, Bosch FX, de Sanjosé S et al. (2003) Epidemiologic Classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527 (Pubitemid 36159887)
14. Doll R, Payne P, Waterhouse J (1966) Cancer incidence in five continents: a technical report. Springer-Verlag (for UICC), Berlin
15. Franceschi S, Rajkumar R, Snijders PJF et al. (2005) Papillomavirus infection in rural women in southern India. Br J Cancer 92:601-606 (Pubitemid 40395546)
16. Dai M, Bao YP, Li N et al. (2006) Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer 95:96-101 (Pubitemid 43980561)
17. Li LK, Dai M, Clifford GM et al. (2006) Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study. Br J Cancer 95:1593-1597 (Pubitemid 44863366)
18. Wu RF, Dai M, Qiao YL et al. (2007) Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer 121:1306-1311 (Pubitemid 47293798)
19. Dondog B, Clifford GM, Vaccarella S et al. (2008) Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev 17:1731-1738
20. Keita N, Clifford GM, Koulibaly M et al. (2009) HPV infection in women with and without cervical cancer in Conakry, Guinea. Br J Cancer 101:865-870
21. Anh PT, Hieu NT, Herrero R et al. (2003) Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 104:213-220 (Pubitemid 36249797)
22. Sukvirach S, Smith JS, Tunsakul S et al. (2003) Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 187:1246-1256 (Pubitemid 36438965)
23. De Vuyst H, Clifford GM, Li N, Franceschi S (2009) HPV infection in Europe. Eur J Cancer 45:2632-2639
24. Thomas JO, Herrero R, Omigbodun AA et al. (2004) Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 90:638-645 (Pubitemid 38297204)
25. Franceschi S, Herrero R, Clifford GM et al. (2006) Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 119:2677-2684 (Pubitemid 44691325)
26. Castle PE, Schiffman M, Herrero R et al. (2005) A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 191:1808-1816 (Pubitemid 40705386)
27. Khan MJ, Castle PE, Lorincz AT et al. (2005) The elevated 10year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 97:1072-1079
28. Vaccarella S, Franceschi S, Herrero R et al. (2006) Sexual behavior, condom use and HPV: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 15:326-333
29. Bardin A, Vaccarella S, Clifford GM et al. (2008) Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer 44:557-564
30. Smith JS, Lindsay L, Hoots B et al. (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121:621-632 (Pubitemid 46986496)
31. Agurto I, Arrossi S, White S et al. (2005) Involving the community in cervical cancer prevention programs. Int J Gynaecol Obstet 89(Suppl 2):S38-S45 (Pubitemid 40488757)
32. Murillo R, Almonte M, Pereira A et al. (2008) Cervical cancer screening programs in Latin America and the Caribbean. Vaccine 26(Suppl 11):L37-L48
33. Garland SM, Cuzick J, Domingo EJ et al. (2008) Recommendations for cervical cancer prevention in Asia Pacific. Vaccine 26(Suppl 12):M89-M98